MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • Noticias
  • Store
  • Corredores
  • Descargar
  • Calendario económico
  • Señales Comerciales
  • WebTerminal
  • English English
  • Русский Русский
  • 中文 中文
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
Mirum Pharmaceuticals, Inc. Common Stock

MIRM

#1168
Mirum Pharmaceuticals, Inc. Common Stock
92.2900
+0.51%
Sector:
Básica:
Profit Currency:
Rango diario
92.1100
92.2900
Rango anual
63.2320
109.2800
Cambio diario
+0.51%
Monthly Change
-8.40%
6 month change
+31.60%
Cambio anual
+31.60%
Cierres anteriores
91.8200
Open
92.1100
Bid
Ask
Low
92.1100
High
92.2900
Volumen
133
  1. Markets
  2. Acciones
  3. Atención Sanitaria
  4. MIRM
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value Q3, 24Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25 TTM

Noticias

Investor's Business Daily Investor's Business Daily
KNSA AUPH HROW ARQT FNV
anteayer, 00:08
Drug Stocks Lead Eight Hot New Names Onto IBD 50 List, Big Cap 20 And More
Investing Investing
MIRM
2026.02.26
Leerink reduce el precio objetivo de Mirum Pharmaceuticals a 118 dólares
Investing Investing
MIRM
2026.02.26
Evercore ISI reitera calificación de Mejor Rendimiento para Mirum Pharmaceuticals
Investing Investing
MIRM
2026.02.26
Leerink recorta precio objetivo de Mirum Pharmaceuticals a $118
Investing Investing
MIRM
2026.02.26
Evercore ISI reitera calificación Outperform para Mirum Pharmaceuticals
Investing Investing
MIRM
2026.02.26
Leerink cuts Mirum Pharmaceuticals stock price target to $118
Investing Investing
MIRM
2026.02.26
Evercore ISI reiterates Mirum Pharmaceuticals stock rating at Outperform
Investing Investing
MIRM
2026.02.26
Las acciones de Mirum Pharmaceuticals caen por las perspectivas de gasto en I+D, RBC reitera Mejor Rendimiento
Investing Investing
MIRM
2026.02.26
Acciones de Mirum caen por gasto en I+D; RBC reitera Outperform
Investing Investing
MIRM
2026.02.26
Mirum Pharmaceuticals stock falls on R&D spending outlook, RBC reiterates Outperform
Zacks Zacks
ADMA RCUS MIRM CSTL
2026.02.26
Mirum's Q4 Earnings Lag, Higher Product Sales Drive Y/Y Revenues
Seeking Alpha Seeking Alpha
MIRM
2026.02.26
Mirum Pharmaceuticals: Nothing Stops This Train (But The Technicals) (NASDAQ:MIRM)

Markets

  • Acciones
  • Divisas
  • Criptomonedas
  • Metales
  • Mercancías

Charts & Ideas

  • Ideas comerciales
  • Ideas ilustrativas
  • Gráfico

MQL5 Community

  • Market
  • Señales
  • Foro
  • Artículos
  • CodeBase

Noticias

  • Acciones
  • Divisas
  • Criptomonedas
  • Metales
  • Mercancías

Corredores

  • Todos los brókeres
  • Fórex
  • Acciones
  • Metales
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Información y contacto Legal
Copyright 2000-2026, MetaQuotes Ltd